StockFame
  • Trending News
  • Markets
  • US Markets
  • Indian Stocks
  • Economics
  • Crypto News
Select Page

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen

by CNBC Markets | February 23, 2026 8:24 pm | US Markets

Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.

Recent Posts

  • Is The Crypto Downturn Web3’s Extinction Event, Or Its Reset?
  • Viral ‘2028 Global Intelligence Crisis’ Report Models Potential AI-Driven S&P 500 Crash To 3,500
  • Hero MotoCorp and 3 Other Auto Stocks to Benefit from CRISIL’s 29 Million Volume Forecast
  • Trump Tariff Aftermath: How Could $175 Bil in Tariff Refunds Turn Into a Double Gain for Companies?
  • US lender Rate unveils mortgage program recognizing crypto holdings

About Stockfame

Stockfame is a global media platform delivering bold insights on business, markets, technology, leadership, and entrepreneurship. We bring you research-backed news and sharp analysis to help you stay ahead of the curve.

Quick News Links

  • Crypto News
  • Indian Stocks
  • Latest Posts
  • Market
  • News
  • Trending News
  • US Markets

Contact Us

Reach out to us at:
Phone:  [+91] 9834938257
Email: contact@stockfame.com
For Advertisement, Press Releases, Partnerships or to get backlinks on this website, please e-mail us at contact@stockfame.com

Quick Reads

  • Global market news
  • Crypto Market News
  • Indian Market News
  • Economy News
  • Latest Business News
  • About
  • Terms and Conditions
  • Privacy Policy
  • Website User Agreement
  • Disclaimer
  • Facebook
  • X
  • Instagram
  • RSS
Copyright @StockFame | All Rights Reserved